Barr's Generic Prozac Will Be Launched By October Following Appeal Victory
Executive Summary
Barr expects to launch its generic fluoxetine before October, the company said, following a federal appellate court decision upholding its patent challenge to Lilly's Prozac.
You may also be interested in...
Lilly Prozac Rehearing Petition Could Receive Ruling By End Of July, Barr Says
Barr expects the D.C. appellate court to rule on Lilly's petition for a rehearing en banc in the Prozac patent infringement case by the end of July.
Lilly Prozac Rehearing Petition Could Receive Ruling By End Of July, Barr Says
Barr expects the D.C. appellate court to rule on Lilly's petition for a rehearing en banc in the Prozac patent infringement case by the end of July.
Cenestin Sales Force Will Promote Seasonale After Barr/Duramed Merger
Barr's oral contraceptive Seasonale will be promoted by Duramed's Cenestin sales force following a merger between the two generic/brand drug companies.